PACB vs PEG · rev $38.4M vs P/E 18, rev $10.29B
Pacific Biosciences of California (PACB) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
PACB currently screens at market cap $387.1M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the PACB and PEG stock pages for the full models.
Not investment advice.